Legal Scrutiny for Dexcom Amid Shareholder Concerns and Class Action Lawsuit

### Dexcom Faces Legal Scrutiny Over Continuous Glucose Monitoring Systems

In a significant development for Dexcom, Inc., a law firm specializing in investor rights, Halper Sadeh LLC, initiates an investigation into potential breaches of fiduciary duties by the company’s officers and directors. This inquiry comes as shareholders voice concerns regarding corporate governance and financial integrity. Long-term investors who hold Dexcom stock are particularly encouraged to engage with the firm, as time may be limited for them to assert their rights. The investigation aims to uncover any misconduct that could impact shareholder value and calls for reforms to enhance transparency and accountability within the company.

Shareholders may consider various remedies that could include financial restitution and corporate governance reforms, emphasizing the necessity for active participation in the company's decision-making processes. Halper Sadeh LLC, operating on a contingent fee basis, points out that clients are not required to pay upfront legal fees, making it more accessible for investors to seek justice. The firm's history of representing global investors who have suffered from corporate misconduct underscores its commitment to recovering losses and implementing necessary reforms. As Dexcom navigates these challenges, the importance of maintaining a vigilant shareholder base becomes paramount.

In a related matter, Rosen Law Firm also announces a class action lawsuit against Dexcom, focusing on allegations of unauthorized changes to its G6 and G7 continuous glucose monitoring systems. The lawsuit claims that these modifications compromise device reliability and pose health risks to users, as they were reportedly made without proper disclosure. Investors who purchased Dexcom securities during a specified period may be eligible for compensation without incurring out-of-pocket costs, highlighting the critical nature of this legal action. With the deadline for potential plaintiffs fast approaching, Rosen Law Firm emphasizes the importance of selecting experienced legal counsel, leveraging its history of significant settlements to advocate for investor rights effectively.

As these legal challenges unfold, both Halper Sadeh LLC and Rosen Law Firm remind Dexcom shareholders of the vital role they play in promoting corporate governance and ensuring accountability. Investors are urged to remain proactive in understanding their rights and the implications of these legal developments on the future of the company.